Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · J.P. Morgan

JPMorgan Healthcare Leaders ETF (JDOC)

Ticker JDOC · Since 2023-11-01 · · Holdings as of Jul 31, 2026

Expense ratio
0.65%$65/yr per $10k
1-yr return
+14.9%as of Dec 2025
Net assets
$9.1Mall share classes
Holdings
61

Bottom line

Is JDOC a good fund? The bottom line

JDOC is an actively managed health care sector ETF from J.P. Morgan.

Its expense ratio is 0.65% — about $65 a year on every $10,000 invested, cheaper than 74% of health care sector funds we track.

It returned +14.9% over one year (as of Dec 31, 2025, per its prospectus).

With $9.1 million in net assets and 61 holdings, its largest position is AbbVie, Inc. (7.8%) and the top 10 make up 48.1% of the portfolio.

The closest lower-cost alternative we found is XLV (0.08%, 62% top-holdings overlap).

What to watch

  • Small fund ($9.1 million) — small funds are likelier to close

Updated Nov 19, 2026

What JDOC invests in

The Fund seeks to provide long-term capital appreciation.

The Fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies (Healthcare Companies) which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. The Fund will invest in common stocks of Healthcare Companies across all market capitalizations, but expects to invest a majority of its assets in mid- and large- capitalization companies. The Fund will invest globally, including in both developed and emerging market countries, although it expects to invest a majority of its Assets in Healthcare Companies located in the U.S. Prior to June 1, 2026, under normal circumstances, the Fund invests at least 80% of its Assets in the equity securities of Healthcare Companies. The adviser…

From the fund's prospectus (filed Apr 30, 2026).

JDOC performance

Fund calendar-year total returns, 2024–2025 2024: −0.6%; 2025: +14.9% −0.6% 2024 +14.9% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
JDOC+14.9%——
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full JDOC performance history →

What JDOC costs

On a $10,000 investment, JDOC's 0.65% expense ratio costs about $65 a year. The prospectus estimates $810 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full JDOC fee table →

JDOC top 10 holdings

#Holding% of fund
1AbbVie, Inc.7.85%
2Eli Lilly & Co.7.76%
3UnitedHealth Group, Inc.5.85%
4Merck & Co., Inc.4.82%
5Johnson & Johnson4.82%
6AstraZeneca plc3.76%
7Thermo Fisher Scientific, Inc.3.73%
8Bristol-Myers Squibb Co.3.57%
9Abbott Laboratories3.11%
10CVS Health Corp.2.83%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 48.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to JDOC

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SPDR (State Street)XLV State Street(R) Health Care Select…0.08%62% Compare
FidelityFHLC Fidelity MSCI Health Care Index ETF0.084%63% Compare
VanguardVGHCX Vanguard Health Care Fund0.33%62% Compare
iSharesIXJ iShares Global Healthcare ETF0.38%68% Compare
SchwabSWHFX Schwab Health Care Fund0.8%57% Compare
T. Rowe PricePRHSX T. Rowe Price Health Sciences Fund, Inc.0.83%58% Compare

More funds like JDOC →

JDOC FAQ

What is the expense ratio of JDOC?
JDOC's expense ratio is 0.65%, which works out to about $65 a year for every $10,000 invested. The prospectus estimates total costs of $810 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is JDOC a good investment?
It depends on your goals, but the data points to: small fund ($9.1 million) — small funds are likelier to close. This is general information, not personalized advice.
What does JDOC hold?
JDOC's largest holdings are AbbVie, Inc. (7.8%), Eli Lilly & Co. (7.8%), UnitedHealth Group, Inc. (5.8%), Merck & Co., Inc. (4.8%), Johnson & Johnson (4.8%). It holds 61 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is a cheaper alternative to JDOC?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) overlaps about 62% with JDOC and charges 0.08%.
Who manages JDOC?
JDOC is offered by J.P. Morgan through J.P. Morgan Exchange-Traded Fund Trust.